SAN DIEGO, Nov. 19, 2021 /PRNewswire/ -- Evofem Biosciences,
Inc., (NASDAQ: EVFM) today announced that Chief Executive
Officer Saundra Pelletier will
participate in a fireside chat and host one-on-one meetings at the
Piper Sandler 33rd Annual Virtual Healthcare Conference
being held from November 29 –
December 2, 2021.
The Company's pre-recorded fireside chat will be available
for on demand listening beginning at 10:00am
ET (7:00am PT) on Monday, November 22, 2021 for 90 days through the
Piper Sandler conference site and at
https://evofem.investorroom.com/Piper2021.
To request a one-on-one meeting with Evofem during the
conference, please contact your Piper Sandler representative.
About Evofem Biosciences
Evofem Biosciences, Inc.,
(NASDAQ: EVFM) is developing and commercializing
innovative products to address unmet needs in women's sexual
and reproductive health, including hormone-free, woman-controlled
contraception and protection from certain sexually transmitted
infections (chlamydia and gonorrhea). The Company's first
FDA-approved product, Phexxi® (lactic acid, citric acid
and potassium bitartrate), is a hormone-free, on-demand
prescription contraceptive vaginal gel. It comes in a box of 12
pre-filled applicators and is applied 0-60 minutes before each act
of sex. Learn more at phexxi.com and evofem.com.
Phexxi® is a registered trademark of Evofem
Biosciences, Inc.
Investor Relations Contact
Amy
Raskopf
Evofem Biosciences, Inc.
araskopf@evofem.com
Mobile: (917) 673-5775
View original content to download
multimedia:https://www.prnewswire.com/news-releases/evofem-biosciences-to-participate-in-piper-sandler-33rd-annual-healthcare-conference-301428861.html
SOURCE Evofem Biosciences, Inc.